Skip to main content

SPEED OF LIFE

– Building a strong and sustainable Life science sector – together

Lokon Pharma – an innovative Swedish cancer therapeutic biotech on their way to market

Lokon Pharma is a biotech company in Sweden based on research from well renowned Uppsala University. They develop a new cancer medicine based on a virus that selectively kill tumor cells and activates the patients own immune system to attack the tumor. It is often described as an immunostimulatory gene therapy.

In this pod, the inventor and CEO Angelica Loskog and the Head of Clinical Development Justyna Leja-Jarblad are discussing what motivates them to pursue such a venturous task as to bring a novel drug to market.

Read more at lokonpharma.com

Presented by Björn Arvidsson and Dajana Ilic S from STUNS Life science, featuring Angelica Loskog, inventor and CEO and Justyna Leja-Jarblad, Head of Clinical Development Lokon Pharma AB.

ABOUT THE PODCAST

SPEED OF LIFE
– Building a strong and sustainable Life science sector – together

Company representatives from the prosperous Life science industry, will share their journey, success strategies and examples concerning entrepreneurship. Business leaders, researchers, marketers, economists, business developers and other experts jointly describe the environment their companies operate in, what drives them and what challenges they face.

Listen, be inspired, learn and take the insights to your company and gain value today!

Picture: Logo of the European Regional Development Fund

Leave a Reply